S. Mccarty

Regulator of calcineurin 1 modulates cancer cell migration in vitro

M. Saji, M. Ringel, M. Shinohara, 2009, Clinical & Experimental Metastasis.

Akt deficiency delays tumor progression, vascular invasion, and distant metastases in a murine model of thyroid cancer

D. Jarjoura, K. L. La Perle, V. Vasko, 2011, Oncogene.

Akt Deficiency Delays Tumor Progression, Vascular Invasion, and Distant Metastases in a Murine Model of Thyroid Cancer Nih Public Access

V. Vasko, M. Saji, M. Ringel, 2011 .

BRAF activates and physically interacts with PAK to regulate cell motility.

M. Saji, M. Ringel, S. Fernandez, 2014, Endocrine-related cancer.

Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.

D. Jarjoura, M. Saji, M. Ringel, 2013, The Journal of clinical endocrinology and metabolism.

Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.

A. Fusco, D. Jarjoura, M. Saji, 2010, Endocrine-related cancer.

Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target.

M. Saji, M. Ringel, J. Phay, 2016, Surgery.

Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro.

Bon Seok Koo, Kyle Porter, David Jarjoura, 2012, Endocrine-related cancer.